Experienced in Palmoplantar Keratoderma

Ramon M. Pujol

Barcelona, CT, ES 
Experienced in Palmoplantar Keratoderma
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Ramon Pujol practices in Barcelona, Spain. Mr. Pujol is rated as an Experienced expert by MediFind in the treatment of Palmoplantar Keratoderma. His top areas of expertise are Guttate Psoriasis, Cutaneous T-Cell Lymphoma (CTCL), Chronic Spontaneous Urticaria (CSU), Hives, and Synovectomy.

His clinical research consists of co-authoring 329 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Palmoplantar Keratoderma.

Gender
Male

Locations

Barcelona, CT, Spain
Other Locations
Mar, AS, Spain
Vic, CT, Spain
Madrid, MD, Spain
Lleida, CT, Spain
Spain
L'hospitalet De Llobregat, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

329 Total Publications

The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain.
The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: August 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pujol's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 22 Advanced Conditions
    View All 95 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile